OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer
Shumin Ouyang, Huaxuan Li, Linlin Lou, et al.
Redox Biology (2022) Vol. 52, pp. 102317-102317
Open Access | Times Cited: 285

Showing 1-25 of 285 citing articles:

System Xc−/GSH/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy
Feng‐Jiao Li, Hui‐Zhi Long, Ziwei Zhou, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 200

Overcoming cancer chemotherapy resistance by the induction of ferroptosis
Yumin Wang, Xiaorui Wu, Ren Zhao, et al.
Drug Resistance Updates (2022) Vol. 66, pp. 100916-100916
Closed Access | Times Cited: 165

Ferroptosis as a potential target for cancer therapy
Zhen Chen, Weilong Wang, Siti Razila Abdul Razak, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 7
Open Access | Times Cited: 105

Cathepsin B in programmed cell death machinery: mechanisms of execution and regulatory pathways
Zhen Xie, Mengyuan Zhao, Chengxiang Yan, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 4
Open Access | Times Cited: 83

Autophagy-Dependent Ferroptosis in Cancer
Fangquan Chen, Xiutao Cai, Rui Kang, et al.
Antioxidants and Redox Signaling (2023) Vol. 39, Iss. 1-3, pp. 79-101
Closed Access | Times Cited: 61

Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects
Qin Ru, Yusheng Li, Lin Chen, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 56

Deciphering drug resistance in gastric cancer: Potential mechanisms and future perspectives
Jiahua Liu, Qihang Yuan, Hui Guo, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116310-116310
Open Access | Times Cited: 17

Augmented ERO1α upon mTORC1 activation induces ferroptosis resistance and tumor progression via upregulation of SLC7A11
Zixi Wang, Huaiyuan Zong, Weiwei Liu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 17

Antioxidant Systems as Modulators of Ferroptosis: Focus on Transcription Factors
Carolina Punziano, Silvia Trombetti, Elena Cesaro, et al.
Antioxidants (2024) Vol. 13, Iss. 3, pp. 298-298
Open Access | Times Cited: 16

Targeting SOX13 inhibits assembly of respiratory chain supercomplexes to overcome ferroptosis resistance in gastric cancer
Hui Yang, Qingqing Li, Xing‐Xing Chen, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 16

Gastric cancer-derived exosomal let-7 g-5p mediated by SERPINE1 promotes macrophage M2 polarization and gastric cancer progression
Zhenzhen Ye, Jianfeng Yi, Xiangyan Jiang, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 5

Patient‐derived xenograft model in cancer: establishment and applications
Ao Gu, Jiatong Li, Mengyao Li, et al.
MedComm (2025) Vol. 6, Iss. 2
Open Access | Times Cited: 5

circASAP1 induces renal clear cell carcinoma ferroptosis by binding to HNRNPC and thereby regulating GPX4
Yunfei Wang, Taowei Yang, Qihao Li, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 3

Reprogramming of TAMs via the STAT3/CD47-SIRPα axis promotes acquired resistance to EGFR-TKIs in lung cancer
Jiaye Lu, Jingwei Li, Ziyou Lin, et al.
Cancer Letters (2023) Vol. 564, pp. 216205-216205
Closed Access | Times Cited: 39

FGFR families: biological functions and therapeutic interventions in tumors
Qing Liu, Jiyu Huang, Weiwei Yan, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 36

Role of ferroptosis in the pathogenesis and as a therapeutic target of inflammatory bowel disease (Review)
Dickson Kofi Wiredu Ocansey, Jintao Yuan, Zhiping Wei, et al.
International Journal of Molecular Medicine (2023) Vol. 51, Iss. 6
Open Access | Times Cited: 35

AIM2 promotes renal cell carcinoma progression and sunitinib resistance through FOXO3a-ACSL4 axis-regulated ferroptosis
Qi Wang, Su Gao, Yi Shou, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 4, pp. 1266-1283
Open Access | Times Cited: 30

Baicalin enhances the efficacy of 5-Fluorouracil in gastric cancer by promoting ROS-mediated ferroptosis
Jingwen Yuan, Shahid Ullah Khan, Junfeng Yan, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114986-114986
Open Access | Times Cited: 30

FANCD2 inhibits ferroptosis by regulating the JAK2/STAT3 pathway in osteosarcoma
Xujun Li, Jiangyi Liu
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 29

TRIM3 facilitates ferroptosis in non-small cell lung cancer through promoting SLC7A11/xCT K11-linked ubiquitination and degradation
Zhangjie Wang, Na Shen, Ziao Wang, et al.
Cell Death and Differentiation (2023) Vol. 31, Iss. 1, pp. 53-64
Closed Access | Times Cited: 29

Ferroptosis in gastrointestinal cancer: from mechanisms to implications
Ruoxi Zhang, Rui Kang, Daolin Tang
Cancer Letters (2023) Vol. 561, pp. 216147-216147
Open Access | Times Cited: 26

Biological functions and molecular interactions of Wnt/β-catenin in breast cancer: Revisiting signaling networks
Mehrdad Hashemi, Sahar Hasani, Shima Hajimazdarany, et al.
International Journal of Biological Macromolecules (2023) Vol. 232, pp. 123377-123377
Closed Access | Times Cited: 25

Novel targets for gastric cancer: The tumor microenvironment (TME), N6-methyladenosine (m6A), pyroptosis, autophagy, ferroptosis and cuproptosis
Peizheng Yang, Wanting Yang, Wei Zhong, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114883-114883
Open Access | Times Cited: 25

Page 1 - Next Page

Scroll to top